ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Shares edge higher; gold stocks bounce back; Westpac tips 25bps May cut, fears tariff fallout; Resmed, Tesla rally; gold ...

Shares edge higher; Trump to reportedly wind down tariff rate on China; Tesla leaps 5pc; ResMed evades trade war blow; iron ...

Discover ResMed's Q3 2025 earnings highlights, including 8% revenue growth, margin expansion, new product launches, and strategic investments in ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. The company manufactures continuous ...

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year ...

Morgans senior healthcare analyst Scott Power says healthcare stocks have had a strong start to the latest reporting season.

ResMed Inc. (ASX: RMD) shares are having a strong finish to the week. Here's why investors are buying this blue chip ...

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: ...

In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...